Search

everythinglearnresearchcommunity

for

Search:↓

Progesterone reduces anxiety and depression in female mice by increasing BDNF in the brain, needing 5α-reduction and estradiol.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

Peptide-based PROTACs show promise in targeting hard-to-treat proteins, especially for cancer therapy.

Agmatine may help reduce seizures linked to hormone changes in female rats.

Prostaglandin D2 blocks new hair growth after skin injury through the Gpr44 receptor.

Parthenolide promotes hair growth in mice and may influence pathways related to male pattern baldness.

Metyrapone effectively stabilizes severe Cushing's disease symptoms before surgery.

Targeting the p300/AR axis may help treat polycystic ovary syndrome.

Drug repurposing shows promise for treating many medical conditions.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

GD-23 reduces anxiety by relying on neurosteroid production.

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.

Some drugs linked to growth hormones may increase the chance of hair loss in women.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

The diphosphonate was the most effective at preventing calcification in rats.

Newer GLP-1 drugs like semaglutide may cause hair loss.

Polyethylene alanine caused hair loss in young lab animals but not in adults, with hair regrowth occurring within 20 days.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

Blocking 5α-reductase can reduce sleep deprivation-related behavioral issues in rats.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Prostaglandins may contribute to male hair loss; targeting them could help treat it.

NAG-1 may help prevent some metabolic issues related to PCOS.

TTNPB helps turn stem cells into neural stem cells, improving depression-like behaviors in rats.

Progesterone and its byproducts control a specific receptor in the brain independently of progesterone receptors, affecting conditions related to the menstrual cycle.

Bimatoprost effectively promotes hair growth.

Combining progesterone with caffeine worsens breathing issues in newborns.

Pramipexole can cause side effects like dizziness, sleepiness, hallucinations, and low blood pressure, and it's important to educate patients and keep doses low.

Upadacitinib effectively treats pyoderma gangrenosum.

PCPA induces hypersexual behavior in male rats regardless of age or castration status.